RC
ZURA icon

Rangeley Capital’s Zura Bio ZURA Stock Holding History

Rangeley Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,000
Closed -$22.1K – 149
2025
Q2 		$22.1K Buy
+21,000
New +$25.1K 0.03% 70

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Rangeley Capital's ZURA Position: Q3 2025 in Review

Rangeley Capital sold out of Zura Bio (ZURA) in Q3 2025, closing a stake of 21,000 shares — an estimated $22.1K sold.

Rangeley Capital first reported a position in ZURA in Q2 2025 and held it in 1 quarter. The position peaked at $22.1K in Q2 2025. 69 funds tracked by Wall St. Rank hold ZURA as of Q3 2025.

  • Rangeley Capital reported no remaining Zura Bio position as of Q3 2025 after selling out during the quarter.
  • Rangeley Capital sold 21,000 Zura Bio shares in Q3 2025, an estimated $22.1K.
  • Rangeley Capital first reported a position in Zura Bio in Q2 2025 and held it in 1 quarter.
  • Rangeley Capital's Zura Bio position peaked at $22.1K in Q2 2025.
  • 69 funds tracked by Wall St. Rank held Zura Bio as of Q3 2025.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.